SAO PAULO, July 26 (Reuters) - China National Pharmaceutical Group Co Ltd (Sinopharm) has applied for emergency use authorization for its COVID-19 vaccine in Brazil, according to a statement from the country's health agency, Anvisa. (Reporting by Anthony Boadle Writing by Ana Mano Editing by Jonathan Oatis)
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Brazil says China's Sinopharm asked for emergency use authorization for its COVID vaccine